KLK3 and prostate carcinoma: Although PSA does not offer very high specificity as a prostate cancer marker [8,9], its concentration in blood along with the ratio of total (tPSA) to free (fPSA) concentrations are now regarded in many countries among the essential parameters to be checked during cancer screening of the male population [10,11].